ES8601853A1 - Procedimiento para la preparacion de alfa-aminoacidos alfa-alenicos - Google Patents

Procedimiento para la preparacion de alfa-aminoacidos alfa-alenicos

Info

Publication number
ES8601853A1
ES8601853A1 ES535188A ES535188A ES8601853A1 ES 8601853 A1 ES8601853 A1 ES 8601853A1 ES 535188 A ES535188 A ES 535188A ES 535188 A ES535188 A ES 535188A ES 8601853 A1 ES8601853 A1 ES 8601853A1
Authority
ES
Spain
Prior art keywords
alpha
allenic
amino acids
kcat
suicide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535188A
Other languages
English (en)
Other versions
ES535188A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of ES535188A0 publication Critical patent/ES535188A0/es
Publication of ES8601853A1 publication Critical patent/ES8601853A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR ALFA-AMINOACIDOS ALFA-ALENICOS. CONSISTENTE EN HIDROLIZAR UN COMPUESTO (I) O (IA) DONDE R'' ES UN GRUPO BLANQUEADOR, R'''' ES UN GRUPO FORMADOR DE ESTER Y R'''''' ES ALQUILO O ACILALQUILO PARA OBTENER LOS COMPUESTOS (II) O (IIA) EN FORMA DE ACIDOS QUE PUEDEN SER CONVERTIDOS EN SALES ESTERES, O AMINAS DONDE A ES UN GRUPO HIDROXILO O HIDROXILO MODIFICADO SIENDO R1, R2, R3 Y R4 RADICALES ALQUILO OPCIONALMENTE SUSTITUIDOS POR HETEROATOMOS O HETEROCICLOS. INHIBIDORES DE DESCARBOXILASAS.
ES535188A 1983-08-17 1984-08-16 Procedimiento para la preparacion de alfa-aminoacidos alfa-alenicos Expired ES8601853A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52447683A 1983-08-17 1983-08-17

Publications (2)

Publication Number Publication Date
ES535188A0 ES535188A0 (es) 1985-12-01
ES8601853A1 true ES8601853A1 (es) 1985-12-01

Family

ID=24089362

Family Applications (3)

Application Number Title Priority Date Filing Date
ES535188A Expired ES8601853A1 (es) 1983-08-17 1984-08-16 Procedimiento para la preparacion de alfa-aminoacidos alfa-alenicos
ES545497A Expired ES8701149A1 (es) 1983-08-17 1985-07-23 Procedimiento para la preparacion de alfa-aminoacidos alfa- alenicos
ES545496A Expired ES8702338A1 (es) 1983-08-17 1985-07-23 Procedimiento para la preparacion de alfa-aminoacidos alfa- alenicos

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES545497A Expired ES8701149A1 (es) 1983-08-17 1985-07-23 Procedimiento para la preparacion de alfa-aminoacidos alfa- alenicos
ES545496A Expired ES8702338A1 (es) 1983-08-17 1985-07-23 Procedimiento para la preparacion de alfa-aminoacidos alfa- alenicos

Country Status (15)

Country Link
EP (1) EP0134561B1 (es)
JP (1) JPS6089459A (es)
KR (1) KR900001182B1 (es)
AT (1) ATE28186T1 (es)
AU (1) AU571559B2 (es)
CA (1) CA1242203A (es)
DE (1) DE3464599D1 (es)
DK (1) DK394284A (es)
ES (3) ES8601853A1 (es)
FI (1) FI843245A (es)
HU (1) HU194808B (es)
IL (1) IL72703A (es)
NO (1) NO168352C (es)
NZ (1) NZ209250A (es)
ZA (1) ZA846388B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3075809U (ja) * 2000-08-23 2001-03-06 新世代株式会社 カラオケ用マイク

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT319993B (de) * 1971-07-14 1975-01-27 Plasser Bahnbaumasch Franz Fahrbare Gleisnivellier-Stopfmaschine
US3855271A (en) * 1973-12-20 1974-12-17 Lilly Co Eli 2-amino-2-allenylmalonic esters
US4178463A (en) * 1978-01-30 1979-12-11 Merrell Toraude Et Compagnie Process for making 4-aminohex-5-enoic acid
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2120244B (en) * 1982-05-17 1985-05-01 Merrell Toraude & Co Aminoalkadiene derivative

Also Published As

Publication number Publication date
NZ209250A (en) 1988-11-29
NO168352B (no) 1991-11-04
ZA846388B (en) 1986-03-26
DK394284A (da) 1985-02-18
ES8702338A1 (es) 1987-01-16
CA1242203A (en) 1988-09-20
NO843273L (no) 1985-02-18
NO168352C (no) 1992-02-12
ATE28186T1 (de) 1987-07-15
ES535188A0 (es) 1985-12-01
IL72703A (en) 1988-11-15
FI843245A (fi) 1985-02-18
DK394284D0 (da) 1984-08-16
DE3464599D1 (de) 1987-08-13
ES545496A0 (es) 1987-01-16
AU571559B2 (en) 1988-04-21
FI843245A0 (fi) 1984-08-16
EP0134561A1 (en) 1985-03-20
JPS6089459A (ja) 1985-05-20
KR900001182B1 (ko) 1990-02-27
ES8701149A1 (es) 1986-12-01
HU194808B (en) 1988-03-28
ES545497A0 (es) 1986-12-01
AU3200584A (en) 1985-02-21
EP0134561B1 (en) 1987-07-08
HUT34950A (en) 1985-05-28
KR850001900A (ko) 1985-04-10
IL72703A0 (en) 1984-11-30

Similar Documents

Publication Publication Date Title
DE3689727T2 (de) Granulierungsverfahren für enzyme.
GR3019289T3 (en) Steroid sulphatase inhibitors
DK163134C (da) Fremgangsmaade til fremstilling af et enzym med fibrinolytisk aktivitet og/eller aktivitet som en plasminogenaktivator
IT8120231A0 (it) Procedimento per la produzione di enzima fruttosil transferasi.
FI843333A (fi) Sodasulfitneutralisering av h202 i kontaktlinser.
EP0104546A3 (en) Therapeutic dipeptides
IT1209526B (it) Metodo per il trattamento enzimatico di polpa pre-spremuta.
ES8702338A1 (es) Procedimiento para la preparacion de alfa-aminoacidos alfa- alenicos
DE3485210D1 (de) Immobilisierte enzymzusammensetzungen.
IT8520090A0 (it) Procedimento di purificazione di un enzima.
AU3207984A (en) Assay based on enzyme cascade amplification
EP0137301A3 (en) 2-ketocarboxylic-acid reductase, its preparation and its use
ES533079A0 (es) Procedimiento para la determinacion cuantitativa de la enzima c1 esterasa.
ZA843828B (en) Angiotensin-converting enzyme inhibitors
DE3381244D1 (de) Enzymehemmer.
ES522638A0 (es) Un producto de enzima inmovilizada.
GB2157698B (en) Enzyme inhibitor
SU1154974A1 (ru) Способ изготовления сегнетокерамической мишени
IE831924L (en) Angiotensin - converting enzyme inhibitors
UA7130A1 (uk) Імуностимулюючий засіб "тімоген"
RO87212B1 (ro) Derivati de p-fluorbenzamida
SU1114135A1 (ru) Манотрон
SU1120886A1 (ru) P-i-n-ДИОД
SU1216940A1 (ru) Способ получения изопрена
SU1244928A1 (ru) Способ получения цис-1,4-полибутадиена

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603